[EMAIL PROTECTED] (William J. Foristal) writes:
On Tue, 5 May 1998 11:29:02 EDT DocCec <[EMAIL PROTECTED]> writes:
>DocCec <[EMAIL PROTECTED]> writes:
>
>
>Actually it closed at something like $57, but still that's way over
>the $12 it
>was going for earlier.
>One of our commentators remarked that it's a wonder no one thought of
>the "cut
>off the blood supply" approach before, and when I started to think
>about that
>it rings true. They've been doing it (experimentally? Ron?) for
>uterine
>fibroids and it seems to work well there, so why not for other solid
>tumors?
>I think it will be several years, maybe as few as five or as many as
>ten,
>before this is ready to be marketed if it does prove workable. But a
>hoax it
>is NOT!
>Cec
Hi Doc,
I would suspect the big difficulty is in being selective about cutting
off the blood supply and not affecting other areas of the body. But I
don't know enough about the processes to begin to guess what all the
major factors are.
I bet Entremed backs off quite a bit in the stock price department the
next several days. I think I'd be taking my profit out right now if I
had been smart enough to invest before the announcement. Of course, I
had never heard of them before the announcement and it's tough to invest
in a company I've never heard of. :)
Bill
_____________________________________________________________________
You don't need to buy Internet access to use free Internet e-mail.
Get completely free e-mail from Juno at http://www.juno.com
Or call Juno at (800) 654-JUNO [654-5866]
Subscribe/Unsubscribe, email: [EMAIL PROTECTED]
In the body of the message enter: subscribe/unsubscribe law-issues
